Recent analyst reports show optimism for several companies, including Apogee Therapeutics, Avadel Pharmaceuticals, and Nvidia, with potential upside for investors. Read more...

A rare-earth minerals deal with Ukraine could generate $20 billion for the US, according to a former Trump economic advisor. Plus, updates on stock buybacks and analyst ratings. Read more...

Analysts issue earnings forecasts for SBC Medical, Nuvalent, and Intrusion, while OptimumBank prepares to announce quarterly results. Logitech announces a share buyback program. Read more...

A summary of recent business news, including an Italian tax investigation into Elon Musk and updates on several companies' stock ratings and earnings estimates. Read more...

A roundup of business news including stock buybacks, company comparisons, earnings reports, analyst ratings, and institutional investment activity. Read more...

Recent analyst ratings for NYSE-listed companies like PBF Energy, Booz Allen, and Wayfair show a mixed bag of recommendations, from 'Reduce' to 'Moderate Buy'. Stock buybacks and institutional investments are also impacting the market. Read more...

William Blair reaffirmed ratings for AvePoint and Biodesix, reiterated a "market perform" for Fortrea, and issued Q1 earnings forecast for Rocket Pharmaceuticals. Read more...